Andrea F. Wainer

Insider Reports History

Location
Wilmington, MA
Signature
Christopher Sefcheck (Attorney in Fact)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrea F. Wainer:

Company Role Class Num Shares Value Price $ Report Date Ownership
ABBOTT LABORATORIES RETIRED EVP Common shares without par value 74,381 $10,277,223 $138.17 03 Mar 2025 Direct
ABBOTT LABORATORIES RETIRED EVP Common shares without par value 70,365 $8,447,318 $120.05 29 Feb 2024 Direct
ANALOG DEVICES INC Director Comm Stock - $.16-2/3 value 1,596 $329,766 $206.62 12 Mar 2025 Direct
NEOGEN CORP Director Common Stock 19,769 $119,997 $6.07 23 Oct 2025 Direct
ANALOG DEVICES INC Director Restricted Stock Unit 185 $40,741 $220.22 18 Feb 2025 Direct
ANALOG DEVICES INC Director Comm Stock - $.16-2/3 value 50 $10,331 $206.62 12 Mar 2025 By Spouse
NEOGEN CORP Director Common Stock (Right to Buy) 50,814 23 Oct 2025 Direct
ABBOTT LABORATORIES RETIRED EVP Option (right to buy) 45,730 25 Feb 2025 Direct

Insider Reports Filed by Andrea F. Wainer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NEOG NEOGEN CORP 23 Oct 2025 2 +$119,998 4 Director 27 Oct 2025, 16:18
NEOG NEOGEN CORP 02 Jun 2025 2 +$34,652 4 Director 04 Jun 2025, 16:08
NEOG NEOGEN CORP 01 Jun 2025 0 $0 3 Director 04 Jun 2025, 16:01
ADI ANALOG DEVICES INC 12 Mar 2025 1 $0 4 Director 14 Mar 2025, 16:50
ABT ABBOTT LABORATORIES 28 Feb 2025 2 -$1,124,741 4 RETIRED EVP 04 Mar 2025, 20:05
ABT ABBOTT LABORATORIES 25 Feb 2025 2 $0 4 EXECUTIVE VICE PRESIDENT 27 Feb 2025, 18:56
ADI ANALOG DEVICES INC 18 Feb 2025 1 $0 4 Director 19 Feb 2025, 16:44
ADI ANALOG DEVICES INC 09 Jan 2025 0 $0 3/A Director 13 Nov 2025, 16:07
ABT ABBOTT LABORATORIES 29 Feb 2024 1 -$1,001,097 4 EXECUTIVE VICE PRESIDENT 04 Mar 2024, 19:22
ABT ABBOTT LABORATORIES 23 Feb 2024 3 -$750,750 4 EXECUTIVE VICE PRESIDENT 27 Feb 2024, 18:13
ABT ABBOTT LABORATORIES 21 Feb 2024 2 $0 4 EXECUTIVE VICE PRESIDENT 23 Feb 2024, 17:45
ABT ABBOTT LABORATORIES 29 Jan 2024 6 -$2,622,300 4 EXECUTIVE VICE PRESIDENT 31 Jan 2024, 17:30
ABT ABBOTT LABORATORIES 14 Dec 2023 3 -$954,000 4 EXECUTIVE VICE PRESIDENT 18 Dec 2023, 17:36
ABT ABBOTT LABORATORIES 08 Aug 2023 8 -$900,297 4 EXECUTIVE VICE PRESIDENT 10 Aug 2023, 18:31
ABT ABBOTT LABORATORIES 02 May 2023 3 -$522,850 4 EXECUTIVE VICE PRESIDENT 03 May 2023, 19:09
ABT ABBOTT LABORATORIES 28 Feb 2023 2 -$819,743 4 EXECUTIVE VICE PRESIDENT 02 Mar 2023, 18:57
ABT ABBOTT LABORATORIES 17 Feb 2023 2 $0 4 EXECUTIVE VICE PRESIDENT 22 Feb 2023, 18:22
ABT ABBOTT LABORATORIES 03 Jun 2022 1 -$207,758 4 EXECUTIVE VICE PRESIDENT 07 Jun 2022, 17:16
ABT ABBOTT LABORATORIES 28 Feb 2022 2 -$803,750 4 EXECUTIVE VICE PRESIDENT 02 Mar 2022, 19:00
ABT ABBOTT LABORATORIES 18 Feb 2022 2 $0 4 EXECUTIVE VICE PRESIDENT 23 Feb 2022, 19:33
ABT ABBOTT LABORATORIES 23 Dec 2021 8 -$1,581,500 4 EXECUTIVE VICE PRESIDENT 28 Dec 2021, 16:41
ABT ABBOTT LABORATORIES 17 Dec 2021 3 -$679,050 4 EXECUTIVE VICE PRESIDENT 21 Dec 2021, 16:34
ABT ABBOTT LABORATORIES 13 Dec 2021 5 -$1,340,500 4 EXECUTIVE VICE PRESIDENT 15 Dec 2021, 17:38
ABT ABBOTT LABORATORIES 06 Dec 2021 3 -$384,750 4 EXECUTIVE VICE PRESIDENT 08 Dec 2021, 16:29
ABT ABBOTT LABORATORIES 15 Nov 2021 5 -$1,102,111 4 EXECUTIVE VICE PRESIDENT 17 Nov 2021, 17:18
ABT ABBOTT LABORATORIES 02 Sep 2021 5 -$807,750 4 EXECUTIVE VICE PRESIDENT 03 Sep 2021, 17:20
ABT ABBOTT LABORATORIES 17 Aug 2021 5 -$1,217,000 4 EXECUTIVE VICE PRESIDENT 19 Aug 2021, 18:27
ABT ABBOTT LABORATORIES 03 Jun 2021 1 -$188,999 4 EXECUTIVE VICE PRESIDENT 07 Jun 2021, 17:33